磁共振成像显示的动脉瘤壁渗透性与颅内动脉瘤症状及瘤壁强化相关
研究前瞻性纳入82例患者共100个未破裂颅内动脉瘤,行3T动态对比增强磁共振成像(DCE-MRI)和血管壁磁共振成像(VWI),评估容积转运常数(Ktrans)与瘤壁强化模式及强化指数(WEI)。症状性动脉瘤的Ktrans和WEI均高于无症状动脉瘤,二者是症状性动脉瘤的独立危险因素且正相关,联合诊断的曲线下面积为0.81。
要点
- 症状性动脉瘤Ktrans中位数2.1 min-1、WEI中位数1.5,均高于无症状动脉瘤。
- Ktrans与WEI正相关(rs=0.41,p<0.001)。
- Ktrans与WEI联合鉴别症状性动脉瘤的AUC为0.81。
核心结论
- Ktrans可能与症状性颅内动脉瘤及瘤壁强化相关,Ktrans和WEI在颅内动脉瘤风险分层方面可能提供优于PHASES评分的附加价值。
研究设计与样本
- 前瞻性研究,连续纳入82例患者共100个未破裂颅内动脉瘤(28个症状性、72个无症状),于2018年1月至2023年3月行3T DCE-MRI和VWI检查。
关键影像表现/征象
- 症状性动脉瘤Ktrans中位数为2.1 min-1,无症状动脉瘤为0.4 min-1(p<0.001)。
- 症状性动脉瘤WEI中位数为1.5,无症状动脉瘤为0.4(p<0.001)。
诊断标准与关键数值
- 症状性动脉瘤定义为伴有哨兵头痛或动眼神经麻痹的未破裂颅内动脉瘤。
- Ktrans为症状性动脉瘤的独立危险因素(OR 1.60,95%CI 1.01-2.52;p=0.04)。
- WEI为症状性动脉瘤的独立危险因素(OR 3.31,95%CI 1.05-10.42;p=0.04)。
- Ktrans与WEI联合鉴别症状性与无症状动脉瘤的AUC为0.81。
临床应用与阅片要点
- 作者认为Ktrans和WEI在颅内动脉瘤风险分层方面可能提供优于PHASES评分的附加价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Wall remodeling and inflammation accompany symptomatic unruptured intracranial aneurysms (UIAs). The volume transfer constant (Ktrans) of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) reflects UIA wall permeability. Aneurysmal wall enhancement (AWE) on vessel wall MRI (VWI) is associated with inflammation. We hypothesized that Ktrans is related to symptomatic UIAs and AWE.
METHODS: Consecutive patients with UIAs were prospectively recruited for 3-T DCE-MRI and VWI from January 2018 to March 2023. UIAs were classified as asymptomatic and symptomatic if associated with sentinel headache or oculomotor nerve palsy. Ktrans and AWE were assessed on DCE-MRI and VWI, respectively. AWE was evaluated using the AWE pattern and wall enhancement index (WEI). Spearman's correlation coefficient and univariate and multivariate analyses were used to assess correlations between parameters.
RESULTS: We enrolled 82 patients with 100 UIAs (28 symptomatic and 72 asymptomatic). The median Ktrans (2.1 versus 0.4 min-1; p < 0.001) and WEI (1.5 versus 0.4; p < 0.001) were higher for symptomatic aneurysms than for asymptomatic aneurysms. Ktrans (odds ratio [OR]: 1.60, 95% confidence interval [95% CI]: 1.01-2.52; p = 0.04) and WEI (OR: 3.31, 95% CI: 1.05-10.42; p = 0.04) were independent risk factors for symptomatic aneurysms. Ktrans was positively correlated with WEI (Spearman's coefficient of rank correlation (rs) = 0.41, p < 0.001). The combination of Ktrans and WEI achieved an area under the curve of 0.81 for differentiating symptomatic from asymptomatic aneurysms.
CONCLUSIONS: Ktrans may be correlated with symptomatic aneurysms and AWE. Ktrans and WEI may provide an additional value than the PHASES score for risk stratification of UIAs.
CLINICAL RELEVANCE STATEMENT: The volume transfer constant (Ktrans) from DCE-MRI perfusion is associated with symptomatic aneurysms and provides additional value above the clinical PHASES score for risk stratification of intracranial aneurysms.
KEY POINTS: • The volume transfer constant is correlated with intracranial aneurysm symptoms and aneurysmal wall enhancement. • Dynamic contrast-enhanced and vessel wall MRI facilitates understanding of the pathophysiological characteristics of intracranial aneurysm walls. • The volume transfer constant and wall enhancement index perform better than the traditional PHASES score in differentiating symptomatic aneurysms.
引用
- Fu Q, Zhang Y, Zhang Y, et al. Wall permeability on magnetic resonance imaging is associated with intracranial aneurysm symptoms and wall enhancement. Eur Radiol. 2024. PMID: 38224377. doi:10.1007/s00330-023-10548-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。